Response To Azacitidine Is Independent Of TP53 Mutations In Higher-Risk Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (sAML)

被引：1
|
作者：
Mueller-Thomas, Catharina
Rudelius, Martina
Rondak, Ina
Haferlach, Torsten
Schanz, Julie
Schmidt, Burkhard
Kremer, Markus
Germing, Ulrich
Platzbecker, Uwe
Peschel, Christian
Goetze, Katharina
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.2797.2797
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2797
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Response to azacitidine is independent of TP53 mutations in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia
    Mueller-Thomas, C.
    Rudelius, M.
    Wolf, P.
    Schanz, J.
    Schmidt, B.
    Platzbecker, U.
    Germing, U.
    Peschel, C.
    Goetze, K.
    LEUKEMIA RESEARCH, 2013, 37 : S73 - S74
  • [2] Response to azacitidine is independent of TP53 mutations in higher-risk MDS
    Mueller-Thomas, C.
    Rudelius, M.
    Wolf, P.
    Schmidt, B.
    Platzbecker, U.
    Germing, U.
    Peschel, C.
    Gotze, K.
    ONKOLOGIE, 2012, 35 : 31 - 31
  • [3] Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia
    Mueller-Thomas, Catharina
    Rudelius, Martina
    Rondak, Ina-Christine
    Haferlach, Torsten
    Schanz, Julie
    Huberle, Christina
    Schmidt, Burkhard
    Blaser, Rainer
    Kremer, Marcus
    Peschel, Christian
    Germing, Ulrich
    Platzbecker, Uwe
    Goetze, Katharina
    HAEMATOLOGICA, 2014, 99 (10) : E179 - E181
  • [4] TP53 MUTATIONS ARE ASSOCIATED WITH COMPLEX CYTOGENETICS IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES AND IMPACT RESPONSE TO AZACITIDINE
    Mueller-Thomas, C.
    Rudelius, M.
    Schmidt, B.
    Peschel, C.
    Platzbecker, U.
    Goetze, K.
    HAEMATOLOGICA, 2012, 97 : 363 - 363
  • [5] Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine
    Bally, Cecile
    Ades, Lionel
    Renneville, Aline
    Sebert, Marie
    Eclache, Virginie
    Preudhomme, Claude
    Mozziconacci, Marie-Joelle
    de The, Hugues
    Lehmann-Che, Jacqueline
    Fenaux, Pierre
    LEUKEMIA RESEARCH, 2014, 38 (07) : 751 - 755
  • [6] Impact of Smoking and TP53 Mutations in Acute Myeloid Leukemia and Myelodysplastic Syndromes
    Bi, Xia
    French, Zachary
    Kasner, Margaret
    Keiffer, Gina
    Wilde, Lindsay
    Palmisiano, Neil
    BLOOD, 2020, 136
  • [7] Prognostic value of TP53 gene mutations in higher-risk MDS treated with azacitidine (AZA)
    Bally, C.
    Ades, L.
    Renneville, A.
    Mozziconacci, M. J.
    Preudhomme, C.
    DeThe, H.
    Lehmann-Che, J.
    Fenaux, P.
    LEUKEMIA RESEARCH, 2013, 37 : S25 - S25
  • [8] The Safety and Tolerability of Azacitidine (AZA) Are Comparable in Patients with Acute Myeloid Leukemia (AML) or Higher-Risk Myelodysplastic Syndromes (MDS)
    Seymour, John F.
    Silverman, Lewis R.
    Doehner, Hartmut
    Fenaux, Pierre
    Mufti, Ghulam J.
    Santini, Valeria
    Minden, Mark D.
    Stone, Richard M.
    Lucy, Lela M.
    Songer, Stephen
    Dougherty, Donna
    Hinkle, Randy
    Gambini, Dominique
    Beach, C. L.
    Dombret, Herve
    BLOOD, 2015, 126 (23)
  • [9] TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
    Welch, J. S.
    Petti, A. A.
    Miller, C. A.
    Fronick, C. C.
    O'Laughlin, M.
    Fulton, R. S.
    Wilson, R. K.
    Baty, J. D.
    Duncavage, E. J.
    Tandon, B.
    Lee, Y-S
    Wartman, L. D.
    Uy, G. L.
    Ghobadi, A.
    Tomasson, M. H.
    Pusic, I.
    Romee, R.
    Fehniger, T. A.
    Stockerl-Goldstein, K. E.
    Vij, R.
    Oh, S. T.
    Abboud, C. N.
    Cashen, A. F.
    Schroeder, M. A.
    Jacoby, M. A.
    Heath, S. E.
    Luber, K.
    Janke, M. R.
    Hantel, A.
    Khan, N.
    Sukhanova, M. J.
    Knoebel, R. W.
    Stock, W.
    Graubert, T. A.
    Walter, M. J.
    Westervelt, P.
    Link, D. C.
    DiPersio, J. F.
    Ley, T. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (21): : 2023 - 2036
  • [10] TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia
    Rahme, Ramy
    Braun, Thorsten
    Manfredi, James J.
    Fenaux, Pierre
    BIOMEDICINES, 2023, 11 (04)
12345